From: The association of angiogenic factors and chronic kidney disease
 | Age, gender, and race-adjusted | Multivariable-adjustedb | ||||
---|---|---|---|---|---|---|
Odds ratios | 95% CI | p-value | Odds ratios | 95% CI | p-value | |
VEGF-A ≥ 160.7 pg/mL | 1.84 | 1.17–2.90 | 0.01 | 2.40 | 1.20–4.81 | 0.01 |
Angiopoietin-1 ≥ 5659.5 pg/mL | 0.87 | 0.55–1.36 | 0.54 | 1.15 | 0.57–2.32 | 0.70 |
Angiopoietin-1/VEGF-A ≤ 24.2 | 3.19 | 2.00–5.10 | < 0.001 | 3.59 | 1.80–7.18 | 0.0003 |
VEGFR-1 ≥ 159.7 ng/mL | 1.10 | 0.70–1.75 | 0.68 | 1.36 | 0.67–2.75 | 0.40 |
VEGFR-2 ≥ 28.3 ng/ml | 1.28 | 0.81–2.01 | 0.29 | 1.11 | 0.55–2.22 | 0.78 |
Pentraxin-3 ≥ 1.13 ng/mL | 1.86 | 1.18–2.94 | 0.008 | 1.74 | 0.86–3.52 | 0.13 |